Dermatology clinical trials
About us
The Alfred's dermatology department is a large tertiary referral centre for adults with all inflammatory and genetic skin conditions, as well as non-melanoma skin cancers.
The unit is focused on new treatments for common conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions such as vitiligo, hidradenitis suppurativa, bullous pemphigoid and urticaria.
Our vision
To advance the development of new treatments for acute severe and chronic on-going skin conditions. We want to improve the quality of life for patients with skin disease and bring more awareness to common and rarer skin conditions.
Are you interested in our clinical trials?
ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.
Find Dermatology clinical trials clinical trials on ClinTrial Refer
Our focus
We currently have trials for the following, but not limited to dermatological conditions:
- Atopic Dermatitis (eczema)
- Psoriasis
- Hidradenitis suppurativa / Acne Inversa
- Urticaria (CSU / CINDU)
- Prurigo Nodularis
- Immunobullous diseases (bullous pemphigoid etc...)
- Ulcerative pyoderma gangrenosum
- Vitiligo
What are Phase I, II, III or IV clinical trials?
There are four different phases of a clinical trial. Each phase is represented by a roman numeral.
Our Team
Johannes is a conjoint Professor and Director of Dermatology, Monash University School of Translational Medicine and Alfred Health and Co-Head of the Monash University SkIIN Discovery Program.
A/Prof Michelle Goh is a Fellow of the Australasian College of Dermatologists (FACD).
Charlotte, our Clinic and Trials Fellow, is a strong patient advocate and has a strong emphasis on patient-centred care.
Melissa Markos is a Registered Nurse with an interest in research to improve treatment options.
Frances Burns is a Registered Nurse with a strong interest in research and improving participants' quality of life.
Publications
Jobson D, Roffey B, Best R, Button-Sloan A, Cossio D, Evans S, Shang C, Moore J, Arnold C, Mann G, Shackleton M, Soyer HP, Morton RL, Zalcberg J, Mar V
(2022), BMJ Open, 12(9), e062139
Honigman A, Kern JS, Frew JW
(2022), Journal of the Australian Wound Management Association, 30(1), 55-61
Bowling J, Paoli J & Chamberlain A (Co-editors)
(2022),
